👩🍳 How we use AI at Tech in Asia, thoughtfully and responsibly.
🧔♂️ A friendly human may check it before it goes live. More news here
🧔♂️ A friendly human may check it before it goes live. More news here
China insurers invest $250m into Hong Kong IPOs
Mainland Chinese insurers have invested more than US$250 million in Hong Kong IPOs, according to UBS.
Low interest rates at home and Beijing’s backing for long-term equity investment push them toward higher-return listings.
UBS said insurers including Ping An, Taikang Life, New China Life, and China Post Life account for most of the activity, which already nears last year’s total.
Insurers became more active this year, while the money has mainly gone to AI, semiconductor, new energy, and biotechnology stocks.
Regulatory changes encouraged insurers to act as long-term capital.
🔗 Source: South China Morning Post
🧠 Food for thought
Implications, context, and why it matters.
Beijing is rewriting insurance investment rules
- China’s National Administration of Financial Regulation (NAFR), the country’s top financial regulator, proposed changes to solvency supervision so insurance funds can play a bigger long-term role as “patient capital,” or long-term investment money 1.
- Regulators cut the risk weights insurers apply to some stock holdings, including shares on Shanghai’s STAR Market, a Nasdaq-style board for science and technology companies. That lowers the capital insurers must keep against those positions 2.
- The lower capital charge comes with minimum holding periods meant to keep money in the market longer 2.
- The change fits a broader push to use insurers’ long-term funds more actively. By the end of 2025, China’s insurance industry had 38.5 trillion yuan (US$5.65 trillion) in funds in use, while policymakers backed support for emerging and future industries 3.
Insurers are taking a larger role in long-term stock investing and Hong Kong IPOs
- The rise in stock investment by insurers also supports government plans to give private equity and venture capital funds more ways to exit, as laid out in the government work report 3.
- Large cornerstone commitments from insurers can give other investors more confidence in Hong Kong initial public offerings (IPOs), including biomedicine deals 4.
- That matters more as Hong Kong became the preferred listing venue for some mainland Chinese companies in 2025 amid valuation limits and slower reviews in mainland China’s A-share IPO market 5.
- Policymakers want insurers to hold more stocks and back emerging industries, instead of leaning mostly on lower-yield assets in a low-rate setting 3.
